---
figid: PMC6826992__cancers-11-01552-g009
figlink: /pmc/articles/PMC6826992/figure/cancers-11-01552-f009/
number: Figure 9
caption: Models of EGFR-ligand dependent pathway and EGFR-ligand independent pathway
  in EIS cells. (A) In the EGFR-ligand dependent pathway, proliferation is promoted
  via ERK/cyclin D1 by EGFR activated by the binding of an EGFR-ligand and EGFR. The
  activity of FAK or sheddase may be involved in EGFR phosphorylation. (B) In the
  EGFR-ligand independent pathway, EGFR transactivated via Src by cell-substratum
  adhesion phosphorylates ErbB3 and promotes proliferation via AKT.
pmcid: PMC6826992
papertitle: Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes
  Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation.
reftext: Masami Nozaki, et al. Cancers (Basel). 2019 Oct;11(10):1552.
pmc_ranked_result_index: '70165'
pathway_score: 0.9100071
filename: cancers-11-01552-g009.jpg
figtitle: Models of EGFR-ligand dependent pathway and EGFR-ligand independent pathway
  in EIS cells
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6826992__cancers-11-01552-g009.html
  '@type': Dataset
  description: Models of EGFR-ligand dependent pathway and EGFR-ligand independent
    pathway in EIS cells. (A) In the EGFR-ligand dependent pathway, proliferation
    is promoted via ERK/cyclin D1 by EGFR activated by the binding of an EGFR-ligand
    and EGFR. The activity of FAK or sheddase may be involved in EGFR phosphorylation.
    (B) In the EGFR-ligand independent pathway, EGFR transactivated via Src by cell-substratum
    adhesion phosphorylates ErbB3 and promotes proliferation via AKT.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT1
  - AKT2
  - EGFR
  - HBEGF
  - EGF
  - EREG
  - EPGN
  - AREG
  - BTC
  - TGFA
  - ERBB3
  - SRC
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGFR-ligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: EGFR-ligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR-ligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EREG
  entrez: '2069'
- word: EGFR-ligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EPGN
  entrez: '255324'
- word: EGFR-ligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: AREG
  entrez: '374'
- word: EGFR-ligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: BTC
  entrez: '685'
- word: EGFR-ligand
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: ErbB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
chemicals: []
diseases: []
---
